SEC Comment Letter 0000000000-23-007868 to LianBio (LIANY) (CIK 0001831283) (LIANY)
LianBio (LIANY) (CIK 0001831283)
Date: July 24, 2023 · CIK: 0001831283 · Accession: 0000000000-23-007868
AI Filing Summary & Sentiment
File numbers found in text: 001-40947
Letter
United States securities and exchange commission logo July 24, 2023 Yi Larson Chief Financial Officer LianBio 103 Carnegie Center Drive, Suite 309 Princeton, NJ 08540 Re:LianBio Form 10-K for Fiscal Year Ended December 31, 2022 Filed March 28, 2023 File No. 001-40947 Dear Yi Larson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
July 24, 2023
Yi Larson
Chief Financial Officer
LianBio
103 Carnegie Center Drive, Suite 309
Princeton, NJ 08540
Re:LianBio
Form 10-K for Fiscal Year Ended December 31, 2022
Filed March 28, 2023
File No. 001-40947
Dear Yi Larson:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences